Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants.

Author: AnkromWendy, ArmasDanielle, BoinpallyRamesh, DockendorfMarissa F, MinK Chris, ValleeMarie-Helene, XuJialin

Paper Details 
Original Abstract of the Article :
The incidence of migraine is higher among women than men and peaks during the reproductive years, when contraceptive medication use is common. Atogepant, a potent, selective antagonist of the calcitonin gene-related peptide receptor-in development for migraine prevention-is thus likely to be used by...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496689/

データ提供:米国国立医学図書館(NLM)

Atogepant and Oral Contraceptives: Exploring Potential Interactions

The study ventures into the intriguing realm of drug interactions, specifically focusing on the potential effects of atogepant, a medication in development for migraine prevention, on the pharmacokinetics of ethinyl estradiol/levonorgestrel, a common combination oral contraceptive. The researchers conducted a phase 1, open-label study involving healthy postmenopausal or oophorectomized women. They found that atogepant, when co-administered with ethinyl estradiol/levonorgestrel, led to a modest increase in the plasma concentration of levonorgestrel. However, this increase was not considered clinically significant. Furthermore, atogepant did not significantly affect the pharmacokinetics of ethinyl estradiol.

Atogepant and Oral Contraceptives: A Harmonious Coexistence

This study provides reassuring evidence that atogepant, when used concurrently with ethinyl estradiol/levonorgestrel, does not pose a significant risk of drug interactions. This finding is crucial for patients who rely on both medications and require reliable contraception. The study also highlights the importance of conducting rigorous research to evaluate potential drug interactions, particularly in cases where multiple medications are being considered.

Navigating the Desert of Medications

The study underscores the importance of careful consideration when combining medications. While the findings suggest that atogepant and ethinyl estradiol/levonorgestrel can be used together safely, this is not always the case for other drug combinations. It is essential to consult with a healthcare professional before starting any new medication, particularly when taking other medications or having pre-existing conditions.

Dr. Camel's Conclusion

Just like a camel navigating the diverse landscape of the desert, navigating the complex world of medications requires a thorough understanding of potential interactions. This study serves as a reminder to be cautious and informed when considering the use of multiple medications. It emphasizes the importance of seeking expert guidance and conducting careful research to ensure safe and effective treatment.

Date :
  1. Date Completed 2021-06-30
  2. Date Revised 2021-06-30
Further Info :

Pubmed ID

32297990

DOI: Digital Object Identifier

PMC7496689

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.